COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 167 filers reported holding COHERUS BIOSCIENCES INC in Q3 2019. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $493,000 | -76.1% | 26,900 | -76.7% | 0.12% | -60.2% |
| Q2 2020 | $2,059,000 | +14.9% | 115,309 | +4.4% | 0.30% | -1.6% |
| Q1 2020 | $1,792,000 | -14.3% | 110,494 | -4.9% | 0.30% | +34.5% |
| Q4 2019 | $2,092,000 | -20.6% | 116,212 | -10.6% | 0.23% | -39.6% |
| Q3 2019 | $2,634,000 | – | 129,992 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 568,408 | $2,125,846 | 18.08% |
| CM Management, LLC | 548,000 | $2,049,520 | 2.18% |
| AlphaCentric Advisors LLC | 912,500 | $3,412,750 | 1.94% |
| Knott David M Jr | 630,000 | $2,356 | 0.90% |
| COURAGE CAPITAL MANAGEMENT LLC | 50,000 | $187 | 0.63% |
| Bridge City Capital, LLC | 276,224 | $1,033,078 | 0.52% |
| Kohlberg Kravis Roberts & Co. L.P. | 3,036,076 | $11,354,924 | 0.40% |
| Ikarian Capital, LLC | 865,787 | $3,238,043 | 0.39% |
| Aristotle Capital Boston, LLC | 2,342,977 | $8,762,734 | 0.28% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $1,496,000 | 0.21% |